“The Effect of Long-Acting Beta-2 Agonist Monotherapy and Long-Acting Anticholinergic Monotherapy to Quality-of-Life in Group B Stable COPD Patients” (2022) Jurnal Respirologi Indonesia, 42(4), pp. 277–281. doi:10.36497/jri.v42i4.370.